SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-127899
Filing Date
2022-04-28
Accepted
2022-04-28 17:05:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d338349ddefa14a.htm DEFA14A 12220
2 GRAPHIC g338349dsp005.jpg GRAPHIC 168623
3 GRAPHIC g338349dsp006.jpg GRAPHIC 43427
  Complete submission text file 0001193125-22-127899.txt   296795
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39756 | Film No.: 22867889
SIC: 2834 Pharmaceutical Preparations